Since the finding that the expression of Fas-ligand (FasL) in melanoma cells caused TIL mortality, the role of the Fas/Fas-ligand pathway in establishing tumoral immune resistance has been debated for several decades.511 T cells separated from cancer patients express more Fas than healthy donors. This evidence concerns the gene FASLG and cancer.